Linked Life Data

12889603

Source:http://linkedlifedata.com/resource/pubmed/id/12889603

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2003-7-31
pubmed:abstractText
Short chain ceramides induce tumor cell apoptosis in preclinical models. Limited therapeutic options for patients with cutaneous breast cancer prompted the testing of these sphingolipids in patients with this disease.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0167-6806
pubmed:author
pubmed:issnType
Print
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
99-104
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:12889603-Administration, Cutaneous, pubmed-meshheading:12889603-Adolescent, pubmed-meshheading:12889603-Adult, pubmed-meshheading:12889603-Aged, pubmed-meshheading:12889603-Antineoplastic Agents, pubmed-meshheading:12889603-Apoptosis, pubmed-meshheading:12889603-Breast Neoplasms, pubmed-meshheading:12889603-Ceramides, pubmed-meshheading:12889603-Female, pubmed-meshheading:12889603-Humans, pubmed-meshheading:12889603-In Situ Nick-End Labeling, pubmed-meshheading:12889603-Middle Aged, pubmed-meshheading:12889603-Patient Selection, pubmed-meshheading:12889603-Prospective Studies, pubmed-meshheading:12889603-Quality of Life, pubmed-meshheading:12889603-Questionnaires, pubmed-meshheading:12889603-Skin Neoplasms, pubmed-meshheading:12889603-Survival Analysis, pubmed-meshheading:12889603-Treatment Failure
pubmed:year
2003
pubmed:articleTitle
A phase II study of topical ceramides for cutaneous breast cancer.
pubmed:affiliation
Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA. jatoi.aminah@mayo.edu
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Multicenter Study, Clinical Trial, Phase II